Mei, Davide Antonio
 Distribuzione geografica
Continente #
AS - Asia 3.437
NA - Nord America 2.941
EU - Europa 1.528
SA - Sud America 483
Continente sconosciuto - Info sul continente non disponibili 85
AF - Africa 63
OC - Oceania 9
Totale 8.546
Nazione #
US - Stati Uniti d'America 2.793
SG - Singapore 1.121
CN - Cina 995
IT - Italia 740
VN - Vietnam 364
BR - Brasile 345
HK - Hong Kong 297
BD - Bangladesh 197
KR - Corea 164
FI - Finlandia 160
GB - Regno Unito 130
DE - Germania 110
RU - Federazione Russa 97
FR - Francia 80
CA - Canada 63
AR - Argentina 57
ID - Indonesia 54
NL - Olanda 50
IN - India 38
MX - Messico 35
SE - Svezia 26
TR - Turchia 23
ES - Italia 22
PL - Polonia 21
UZ - Uzbekistan 19
CO - Colombia 18
AT - Austria 17
EC - Ecuador 17
JP - Giappone 17
PK - Pakistan 17
IQ - Iraq 16
AE - Emirati Arabi Uniti 15
CL - Cile 15
TW - Taiwan 15
ZA - Sudafrica 15
UA - Ucraina 14
SA - Arabia Saudita 13
JM - Giamaica 12
LT - Lituania 12
VE - Venezuela 12
EG - Egitto 10
BE - Belgio 9
MA - Marocco 9
TH - Thailandia 9
AU - Australia 8
AZ - Azerbaigian 7
CR - Costa Rica 7
KE - Kenya 7
SV - El Salvador 7
TN - Tunisia 7
GE - Georgia 6
GT - Guatemala 6
KZ - Kazakistan 6
BO - Bolivia 5
CU - Cuba 5
DZ - Algeria 5
IL - Israele 5
JO - Giordania 5
OM - Oman 5
PE - Perù 5
PH - Filippine 5
PT - Portogallo 5
PY - Paraguay 5
BG - Bulgaria 4
IE - Irlanda 4
MY - Malesia 4
RO - Romania 4
UY - Uruguay 4
AM - Armenia 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
NP - Nepal 3
RS - Serbia 3
TT - Trinidad e Tobago 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
CY - Cipro 2
KG - Kirghizistan 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
SN - Senegal 2
AO - Angola 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
KH - Cambogia 1
LB - Libano 1
Totale 8.447
Città #
Singapore 704
Hefei 500
San Jose 414
Ashburn 380
Santa Clara 365
Hong Kong 293
Council Bluffs 217
Seoul 164
Beijing 130
Ho Chi Minh City 123
Los Angeles 113
Helsinki 110
Hanoi 87
New York 87
London 80
Milan 74
The Dalles 63
Chicago 61
Bologna 59
Buffalo 54
Rome 53
Lauterbourg 46
Dallas 43
Munich 42
São Paulo 37
Jakarta 36
Lappeenranta 36
Boardman 32
Modena 31
Kent 29
Moscow 29
Shanghai 26
Salt Lake City 25
Frankfurt am Main 23
Orem 23
Mexico City 21
Amsterdam 18
Da Nang 17
Naples 17
Nuremberg 17
Tashkent 17
Haiphong 16
Montreal 16
Portsmouth 15
Phoenix 14
Turin 14
Warsaw 14
Chandler 13
Fairfield 13
Nyköping 13
Seattle 13
Tokyo 13
Turku 13
Curitiba 12
Houston 12
Brooklyn 11
Rio de Janeiro 11
Toronto 11
Atlanta 10
Chennai 10
Düsseldorf 10
Paris 10
Santiago 10
Stockholm 10
Tampa 10
Hangzhou 9
Istanbul 9
Miami 9
Salvador 9
Bari 8
Brescia 8
Campinas 8
Catania 8
Columbus 8
Elk Grove Village 8
Manchester 8
Newark 8
Perugia 8
Vienna 8
Biên Hòa 7
Brussels 7
Calgary 7
Carpi 7
Florence 7
Fortaleza 7
Hillsboro 7
Hải Dương 7
Mumbai 7
North Bergen 7
Palermo 7
Parma 7
Pittsburgh 7
Quito 7
Redondo Beach 7
Reggio Emilia 7
San Salvador 7
Boston 6
Bắc Ninh 6
Can Tho 6
Denver 6
Totale 5.249
Nome #
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 284
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 284
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice 267
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 264
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting 231
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 231
Remote monitoring and telemedicine in heart failure: implementation and benefits 226
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? 209
Single-lead VDD pacing: a literature review on short-term and long-term performance 204
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 202
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 181
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study 175
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 174
Association of comorbidity patterns with outcomes and relation with the ABC pathway effectiveness in European patients with atrial fibrillation 174
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review 172
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 170
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications 162
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry 162
Systematic review and meta-Analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing 161
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices 157
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 156
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction 155
Clinical decisions for appropriate management of patients with atrial fibrillation 155
Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: An analysis from the GLORIA-AF registry 151
Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation 151
Atrial Fibrillation Ablation in Patients Recently Hospitalized for Worsening Heart Failure: Need for Individualized Decision-Making 143
Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry 139
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries 135
Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry 132
CHA2DS2-VA instead of CHA2DS2-VASc for stroke risk stratification in patients with atrial fibrillation: not just a matter of sex 130
Atrial fibrillation, comorbidities, stroke, and mortality in real‑world clinical practice 127
Left and right atrial echocardiographic parameters and outcome in patients with atrial fibrillation 126
Detection and management of postoperative atrial fibrillation after coronary artery bypass grafting or non-cardiac surgery: a survey by the AF-SCREEN International Collaboration 125
Antiarrhythmic drugs in the era of atrial fibrillation ablation 120
Therapeutic effects of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: From outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progression and atrial cardiomyopathy 119
Provision of care in clinical cardiac electrophysiology during and after the COVID-19 pandemic: An open challenge for health care systems 118
Prepare our healthcare systems to manage complexity: the case of atrial fibrillation 112
Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry 111
Multimorbidity in atrial fibrillation: A call for integrated patient-centered care 106
Mobile/wearable digital devices for care of active cancer patients: a survey from the ESC Council of Cardio-Oncology 104
Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry 102
Efficacy of the ABC Pathway for Integrated Care Across Phenotypes of Patients with Atrial Fibrillation: A Latent-Class Analysis Report from the mAFA-II Clinical Trial 96
Atrial fibrillation screening: The importance of the patient perspective 93
Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III 92
Real-World Use of ARNI Within GDMT in HFrEF Patients with and Without Atrial Fibrillation: A Retrospective Analysis of Cardiac and Renal Functions and Clinical Outcomes 92
Atrial fibrillation and female sex: use of oral anticoagulants in a large European cohort and residual risk of thromboembolism and stroke 84
Chronic kidney disease classification according to different formulas and impact on adverse outcomes in patients with atrial fibrillation: A report from a prospective observational European registry 84
Economic Evaluations in Electrophysiology in the Last 15 Years: A Systematic Review of the Literature 77
A European-Multicenter Network for the Implementation of Artificial Intelligence to Manage Complexity and Comorbidities of Atrial Fibrillation Patients: The ARISTOTELES Consortium 71
Subclinical atrial fibrillation/atrial high-rate episodes: what significance and decision-making? 69
Physical activity in patients with atrial fibrillation and adverse outcomes: results from a large-scale prospective multicenter European cohort 69
Flecainide and atrial fibrillation cardioversion: what solutions at present and in the near future? 64
Educational status affects prognosis of patients with heart failure with reduced ejection fraction: A post‐hoc analysis from the WARCEF trial 61
Sex-related differences in presentation, treatment, and outcomes of Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry 60
Female sex as risk factor for undertreatment: need for a paradigm shift in the care of atrial fibrillation and ischaemic disease 56
Stroke prevention in atrial fibrillation patients with end-stage renal disease: how far from Ithaca after a long Odyssey? 54
Antiarrhythmic drugs and ablation in patients with atrial fibrillation: New perspectives 51
Multimorbidity, frailty and polypharmacy in European and Asian patients with atrial fibrillation: a comparison of two regional prospective observational registries 51
Atrial fibrillation ablation in the perspective of holistic patient-centred care: all-cause mortality as an outcome of reference at long-term 51
Personalized clinical management of patients with atrial fibrillation: is a biomarker-based strategy for prediction of sinus rhythm persistence ready for prime time? 49
Artificial intelligence in patients with atrial fibrillation to manage clinical complexity and comorbidities: the ARISTOTELES project 46
Cost-consequence analysis of three cardiac ablation technologies in paroxysmal atrial fibrillation 46
Mineralocorticoids and outcome improvement in heart failure patients with and without atrial fibrillation: a systematic review and a meta-analysis 45
A multistate model of clinical trajectories of heart failure patients with implantable electronic devices followed with remote monitoring: What outcome implications of alerts at long term follow up? 33
From fixed time points to personalized care: rethinking stroke risk management in atrial fibrillation patients 30
Detection of left ventricular hypertrophy through ECG: diagnostic performance and comparison of ten ECG scores in different hypertrophic conditions 30
The intriguing relationships between atrial fibrillation and heart failure: insights from cardiac implantable electronic devices 29
Impact of cardiovascular-kidney-metabolic conditions on clinical outcomes in patients with atrial fibrillation: results from a prospective cohort 27
Application of Artificial Intelligence in the Early Detection and Management of Atrial Fibrillation: State-of-the-art Review 23
Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA-AF Registry Phase III 23
Liver disease in management and outcomes of European and Asian patients with atrial fibrillation: A report from two observational prospective registries 18
Evolution in the approach to atrial fibrillation: from screening for asymptomatic episodes to implementing artificial intelligence for refined risk prediction 17
Renal function in patients with atrial fibrillation: From Virchow's triad to real-world practice 15
In patients with chronic coronary syndrome and high atherothrombotic risk, adding aspirin to OAC increased adverse CV events at 2 y 14
Intensification of monitoring for improving detection of atrial fibrillation after a presumed "trigger- induced episode" due to potentially reversible factors: what tools and what implications for decision making? 12
Impact of Left Bundle Branch Pacing on Left Ventricular Mechanical Efficiency 7
Totale 8.546
Categoria #
all - tutte 36.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202229 0 0 1 0 2 6 0 0 1 3 6 10
2022/2023110 7 6 8 7 5 5 4 12 15 6 27 8
2023/2024427 5 18 26 52 109 47 39 44 9 15 20 43
2024/20251.783 24 12 17 76 205 282 168 139 186 131 292 251
2025/20265.333 342 233 378 662 600 233 693 306 629 490 393 374
2026/2027849 280 437 132 0 0 0 0 0 0 0 0 0
Totale 8.546